ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD16.32

D16.32

Billable

Benign neoplasm of short bones of left lower limb

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D16.32 is a billable code used to indicate a diagnosis of benign neoplasm of short bones of left lower limb.

Key Diagnostic Point:

Benign neoplasms of the short bones of the left lower limb, such as those found in the tarsal and metatarsal regions, are non-cancerous growths that can arise from various tissues including bone, cartilage, and fibrous tissue. These neoplasms may present as asymptomatic masses or may cause discomfort, pain, or functional impairment depending on their size and location. Common types of benign neoplasms in this area include osteochondromas, enchondromas, and fibromas. Diagnosis typically involves imaging studies such as X-rays, MRI, or CT scans to assess the characteristics of the neoplasm. While benign, these neoplasms require monitoring due to the potential for growth or complications, such as fracture or compression of adjacent structures. Regular follow-up and imaging may be necessary to ensure stability and to rule out any malignant transformation, although this is rare. Treatment options may include observation, surgical excision, or other interventions based on symptoms and the specific type of neoplasm.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation between benign and malignant neoplasms
  • Need for precise anatomical localization
  • Variability in clinical presentation and symptoms
  • Potential for misclassification with similar codes

Audit Risk Factors

  • Inadequate documentation of the neoplasm's characteristics
  • Failure to specify the exact location of the neoplasm
  • Lack of follow-up documentation indicating monitoring
  • Misuse of codes for malignant neoplasms

Specialty Focus

Medical Specialties

Orthopedic Surgery

Documentation Requirements

Detailed imaging reports, surgical notes, and follow-up assessments.

Common Clinical Scenarios

Surgical excision of a symptomatic benign neoplasm or monitoring of an asymptomatic lesion.

Billing Considerations

Ensure clear documentation of the neoplasm's size, location, and any symptoms to support the diagnosis.

Radiology

Documentation Requirements

Comprehensive imaging reports detailing the characteristics of the neoplasm.

Common Clinical Scenarios

Imaging studies performed to evaluate a suspected benign neoplasm.

Billing Considerations

Accurate descriptions of imaging findings are crucial for proper coding.

Coding Guidelines

Inclusion Criteria

Use D16.32 When
  • Follow the official ICD
  • CM coding guidelines, ensuring that the diagnosis is supported by clinical documentation
  • Include specific details about the neoplasm's characteristics and location

Exclusion Criteria

Do NOT use D16.32 When
  • Exclude codes for malignant neoplasms unless there is clear evidence of malignancy

Related ICD-10 Codes

Related CPT Codes

20610CPT Code

Arthrocentesis, aspiration and/or injection into a major joint or bursa

Clinical Scenario

Used when a benign neoplasm causes joint effusion.

Documentation Requirements

Document the indication for the procedure and findings.

Specialty Considerations

Orthopedic specialists should ensure clarity in the reason for the procedure.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. D16.32 provides a clear distinction from malignant neoplasms, which is crucial for patient management and treatment planning.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. D16.32 provides a clear distinction from malignant neoplasms, which is crucial for patient management and treatment planning.

Reimbursement & Billing Impact

reimbursement processes. D16.32 provides a clear distinction from malignant neoplasms, which is crucial for patient management and treatment planning.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the significance of coding D16.32 accurately?

Accurate coding of D16.32 is essential for proper patient management, ensuring appropriate treatment plans, and facilitating accurate reimbursement. It also aids in the collection of data for epidemiological studies and healthcare planning.